| 2026-09-08 | 8-K | Form 8-K, Item 7.01 |
| 2026-09-04 | 8-K | Form 8-K, Item 1.01 |
| 2026-08-07 | Press release | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-08-06 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-06 | Press release | Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates |
| 2026-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-06 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-04 | Deck | Corporate Presentation |
| 2026-07-30 | Press release | Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business |
| 2026-07-06 | Press release | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-06-15 | 8-K | Form 8-K, Item 7.01 |
| 2026-06-13 | Press release | Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with H |
| 2026-06-10 | 8-K | Form 8-K, Item 5.07 |
| 2026-06-05 | Press release | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-06-01 | Press release | Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral |
| 2026-05-11 | Press release | Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates |
| 2026-05-11 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-11 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-05 | Press release | Intellia Therapeutics to Participate in Upcoming Investor Conferences |
| 2026-05-01 | Press release | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-04-30 | Proxy | Definitive proxy statement |
| 2026-04-30 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-29 | Press release | Press release · Apr 2026 |
| 2026-04-27 | Press release | Press release · Apr 2026 |
| 2026-04-27 | Press release | Press release · Apr 2026 |
| 2026-04-27 | Press release | Press release · Apr 2026 |
| 2026-04-27 | Deck | HAELO Topline Data Presentation |
| 2026-04-27 | 8-K | Form 8-K, Item 7.01 |
| 2026-04-24 | Press release | Press release · Apr 2026 |
| 2026-04-10 | 8-K | Form 8-K, Item 5.03 |
| 2026-04-03 | Press release | Press release · Apr 2026 |
| 2026-03-06 | Press release | Press release · Mar 2026 |
| 2026-03-03 | Press release | Press release · Mar 2026 |
| 2026-03-02 | Press release | Press release · Mar 2026 |
| 2026-03-02 | 8-K | Form 8-K, Item 1.01 |
| 2026-03-01 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-26 | Press release | Press release · Q4 2025 · Feb 2026 |
| 2026-02-26 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-26 | 10-K | Annual report on Form 10-K, FY25 |